One patient presented with one breast cancer in each breast which were of different tumor biology; we therefore considered this patient as two separate cases (ID 6: IDC ER/PR negative, Her2 positive, and Ki67 90%; ID 7: IDC ER/PR positive, Her2 negative, and Ki67 20%). Here, ERBB2 is linked to breast carcinoma.